NasdaqGS - Delayed Quote USD
Ionis Pharmaceuticals, Inc. (IONS)
35.29
+0.05
+(0.14%)
At close: June 6 at 4:00:01 PM EDT
35.72
+0.43
+(1.22%)
After hours: June 6 at 5:11:27 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 10 | 10 |
| Avg. Estimate | 0.1 | -0.86 | -2.4 | -1.86 |
| Low Estimate | -0.64 | -1.16 | -3.12 | -2.64 |
| High Estimate | 0.61 | -0.44 | -2 | -0.4 |
| Year Ago EPS | -0.24 | -0.72 | -2.16 | -2.4 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 17 | 24 | 24 |
| Avg. Estimate | 277.75M | 162.86M | 747.61M | 873.68M |
| Low Estimate | 127.6M | 98M | 715.3M | 722.5M |
| High Estimate | 394.29M | 246.3M | 801M | 1.29B |
| Year Ago Sales | 225M | 134M | 705M | 747.61M |
| Sales Growth (year/est) | 23.44% | 21.54% | 6.04% | 16.86% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.76 | -0.98 | -0.84 | -1.03 |
| EPS Actual | -0.24 | -0.72 | -0.43 | -0.92 |
| Difference | 0.52 | 0.26 | 0.41 | 0.11 |
| Surprise % | 68.59% | 26.14% | 49.03% | 10.39% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.1 | -0.86 | -2.4 | -1.86 |
| 7 Days Ago | 0.1 | -0.86 | -2.4 | -1.86 |
| 30 Days Ago | -0.87 | -0.79 | -3.03 | -2.12 |
| 60 Days Ago | -0.8 | -0.7 | -2.8 | -2.2 |
| 90 Days Ago | -0.83 | -0.73 | -2.88 | -2.31 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | 5 |
| Up Last 30 Days | 1 | -- | 6 | 5 |
| Down Last 7 Days | -- | 2 | -- | -- |
| Down Last 30 Days | -- | 2 | 3 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IONS | 143.50% | -19.05% | -11.17% | 22.69% |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/20/2025 |
| Maintains | Guggenheim: Buy to Buy | 5/1/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/1/2025 |
| Maintains | Needham: Buy to Buy | 4/30/2025 |
| Reiterates | Needham: Buy to Buy | 4/15/2025 |
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
Related Tickers
ALNY Alnylam Pharmaceuticals, Inc.
300.83
-2.33%
ARWR Arrowhead Pharmaceuticals, Inc.
16.81
+2.13%
AGIO Agios Pharmaceuticals, Inc.
34.33
+2.23%
BMRN BioMarin Pharmaceutical Inc.
56.65
+2.50%
PTCT PTC Therapeutics, Inc.
52.13
+0.77%
RVMD Revolution Medicines, Inc.
41.09
+2.21%
ACAD ACADIA Pharmaceuticals Inc.
21.98
+3.00%
CYTK Cytokinetics, Incorporated
32.30
+0.69%
JAZZ Jazz Pharmaceuticals plc
111.13
+2.14%
RARE Ultragenyx Pharmaceutical Inc.
37.17
+0.69%